Jim Cramer wrote in a column Wednesday that there is no shortage of bright spots in the stock market, especially in the science and innovation space. Cramer singled out vaccine maker Moderna (MRNA) as one such bright spot. Shares of Moderna have rallied significantly over the past 12 months. Is there more room to rally? Let's check out the charts and indicators.
More from Investing
As the correction goes on, here's what to do now.
The next good sized bounce in SPAC names, and maybe ARKK names, might be the last exit off the bagholder highway.
Has the reopening news already been priced in? The charts are telling investors to look out ahead.